ItalianoCIVALLERO, Monica
Dettaglio
CIVALLERO, Monica
Dipartimento Chirurgico,Medico,Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa
Pubblicazioni
Risultati 1 - 20 di 21 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Activity of BKM120 and BEZ235 against lymphoma cells | 2015 | Civallero, Monica; Cosenza, Maria; Pozzi, Samantha; Bari, Alessia; Ferri, Paola; Sacchi, Stefano |
| 2 | ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project | 2021 | Shustov, A.; Cabrera, M. E.; Civallero, M.; Bellei, M.; Ko, Y. H.; Manni, M.; Skrypets, T.; Horwitz, S. M.; de Souza, C. A.; Radford, J. A.; Bobillo, S.; Prates, M. V.; Ferreri, A. J. M.; Chiattone, C.; Spina, M.; Vose, J. M.; Chiappella, A.; Laszlo, D.; Marino, D.; Stelitano, C.; Federico, M.; Savage, K.; Connors, J.; Gascoyne, R.; Chhanabhai, M.; Wilson, W.; Jaffe, E. S.; Armitage, J. O.; Weisenburger, D. D.; Anderson, J.; Ullrich, F.; Bast, M.; Hochberg, E.; Harris, N.; Smogorzews ka, A.; Levine, A.; Nathwani, B. N.; Miller, T.; Rimsza, L.; Montserrat, E.; Lopez-Guillermo, A.; Campo, E.; Cuadros, M.; Ferreira, J. A.; Delgado, B. M.; Holte, H.; Delabie, J.; Rudiger, T.; Muller-Hermelink, K.; Reimer, P.; Adam, P.; Wilhelm, M.; Schmitz, N.; Nerl, C.; Lister, A.; Norton, A.; MacLennan, K. A.; Zinzani, P. L.; Pileri, S. A.; Bellai, M.; Luminari, S.; Coiffier, B.; Berger, F.; Tanin, I.; Wannakrairot, P.; Au, W. Y.; Liang, R.; Loong, F.; Rajan, S.; Sng, I.; Tobinai, K.; Matsuno, Y.; Morishima, Y.; Nakamura, S.; Seto, M.; Tanimoto, M.; Yoshino, T.; Suzumiya, J.; Ohshima, K.; Kim, W. -S. |
| 3 | Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts | 2005 | Cosenza, Maria; Civallero, Monica; Sacchi, Stefano; Marcheselli, Raffaella; Pozzi, Samantha |
| 4 | Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery | 2015 | Civallero, Monica; Vergaro, Viviana; Citti, Cinzia; Cosenza, Maria; Cannazza, Giuseppe; Parenti, Carlo; Bari, Alessia; Ciccarella, Giuseppe; Sacchi, Stefano; Pozzi, Samantha |
| 5 | Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma | 2018 | Vergaro, Viviana; Civallero, Monica; Citti, Cinzia; Cosenza, Maria; Baldassarre, Francesca; Cannazza, Giuseppe; Pozzi, Samantha; Sacchi, Stefano; Fanizzi, Francesco Paolo; Ciccarella, Giuseppe |
| 6 | Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination | 2020 | Cosenza, M.; Civallero, M.; Marcheselli, L.; Sacchi, S.; Pozzi, S. |
| 7 | The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines | 2015 | Cosenza, Maria; Civallero, Monica; Pozzi, Samantha; Marcheselli, Luigi; Bari, Alessia; Sacchi, Stefano |
| 8 | Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines | 2012 | Cosenza, Maria; Civallero, Monica; Grisendi, Giulia; Marcheselli, Luigi; Roat, Erika; Bari, Alessia; Sacchi, Stefano |
| 9 | Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. | 2010 | Civallero, Monica; Cosenza, Maria; Grisendi, Giulia; Marcheselli, L; Todoerti, K; Sacchi, Stefano |
| 10 | Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 | 2008 | Sacchi, Stefano; Civallero, Monica; Cosenza, Maria; Grisendi, Giulia; Luigi, Marcheselli; Antonino, Neri |
| 11 | Genomic profiling of enzastaurin-treated B cell lymphoma RL cells | 2011 | Civallero, Monica; Cosenza, Maria; Neri, Antonino; Bari, Alessia |
| 12 | The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines | 2016 | Cosenza, Maria; Civallero, Monica; Fiorcari, Stefania; Pozzi, Samantha; Marcheselli, Luigi; Bari, Alessia; Ferri, Paola; Sacchi, Stefano |
| 13 | Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas | 2020 | Foss, Francine M; Horwitz, Steven M; Civallero, Monica; Bellei, Monica; Marcheselli, Luigi; Kim, Won Seog; Cabrera, Maria E; Dlouhy, Ivan; Nagler, Arnon; Advani, Ranjana H; Pesce, Emanuela A; Ko, Young-Hyeh; Montoto, Silvia; Chiattone, Carlos; Moskowitz, Alison; Spina, Michele; Cesaretti, Marina; Biasoli, Irene; Federico, Massimo |
| 14 | Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression. | 2009 | Verdelli, D; Nobili, L; Todoerti, K; Intini, D; Cosenza, Maria; Civallero, Monica; Bertacchini, Jessika; Deliliers, Gl; Sacchi, Stefano; Lombardi, L; Neri, A. |
| 15 | NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy | 2012 | Civallero, Monica; Cosenza, Maria; Marcheselli, Luigi; Pozzi, Samantha; Sacchi, Stefano |
| 16 | Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma | 2011 | Civallero, Monica; Cosenza, Maria; Bari, Alessia; Sacchi, Stefano |
| 17 | Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine | 2017 | Cosenza, Maria; Civallero, Monica; Marcheselli, Luigi; Sacchi, Stefano; Pozzi, Samantha |
| 18 | Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases | 2017 | Civallero, Monica; Cosenza, Maria; Pozzi, Samantha; Sacchi, Stefano |
| 19 | Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply | 2020 | Fox, C. P.; Civallero, M.; Federico, M.; Kim, W. S. |
| 20 | Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project | 2020 | Fox, C. P.; Civallero, M.; Ko, Y. -H.; Manni, M.; Skrypets, T.; Pileri, S.; Kim, S. J.; Cabrera, M. E.; Shustov, A. R.; Chiattone, C. S.; Horwitz, S. M.; Dlouhy, I.; Spina, M.; Hitz, F.; Montoto, S.; Nagler, A.; Martinez, V.; De Souza, C. A.; Fernandez-Alvarez, R.; Ballova, V.; Gabus, R.; Inghirami, G.; Federico, M.; Kim, W. S. |
Copyright © 2021